In-silico discovery of cancer-specific peptide-HLA complexes for targeted therapy

BACKGROUND: Major Histocompatibility Complex (MHC) or Human Leukocyte Antigen (HLA) Class I molecules bind to peptide fragments of proteins degraded inside the cell and display them on the cell surface. We are interested in peptide-HLA complexes involving peptides that are derived from proteins spec...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhanik, Ankur, R. Kirshner, Jessica, MacDonald, Douglas, Thurston, Gavin, C. Lin, Hsin, J. Murphy, Andrew, Zhang, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955262/
https://www.ncbi.nlm.nih.gov/pubmed/27439771
http://dx.doi.org/10.1186/s12859-016-1150-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955262/
https://www.ncbi.nlm.nih.gov/pubmed/27439771
http://dx.doi.org/10.1186/s12859-016-1150-2

Ejemplares similares